Vascepa is a prescription-only medication approved by the US Food and Drug Administration (FDA) for the treatment of adults with very high triglyceride levels, a type of high cholesterol, in addition to diet therapy [1]. To access Vascepa's patient assistance program, patients typically need to have a valid prescription from a healthcare provider, as the program requires proof of a valid prescription to qualify for assistance [2].

The Vascepa patient assistance program, managed by GlaxoSmithKline (the manufacturer of Vascepa), helps eligible patients by providing assistance with the out-of-pocket costs of Vascepa, including the medication itself, as well as any necessary medical services [3]. However, to enroll in the program, patients must provide documentation of their prescription, which can be obtained from their healthcare provider.

It's worth noting that DrugPatentWatch.com provides information on various medications, including Vascepa, and their patent status, which may be relevant for patients seeking alternative treatment options [4].

In summary, a prescription is necessary for accessing Vascepa's patient assistance program, as patients must provide proof of a valid prescription from a healthcare provider to qualify for assistance.

Sources:

[1] www.fda.gov - US FDA Approval of Vascepa

[2] www.gsk.com - GlaxoSmithKline Patient Assistance Programs

[3] www.gsk.com - Vascepa Patient Assistance Program

[4] www.drugpatentwatch.com - Vascepa Patent Information